Preimplantation Genetics Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030

Preimplantation Genetics Diagnosis Trends and Forecast

The future of the global preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets. The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030 with a CAGR of 10.7% from 2024 to 2030. The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

A more than 150-page report is developed to help in your business decisions.

Preimplantation Genetics Diagnosis by Segment

The study includes a forecast for the global preimplantation genetics diagnosis by type, end use, and region.

Preimplantation Genetics Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Chromosomal Abnormalities
• Aneuploidy
• X-linked diseases
• Single Gene Disorders
• HLA Typing
• Gender selection
• Others

Preimplantation Genetics Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Clinics
• Others

Preimplantation Genetics Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Preimplantation Genetics Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preimplantation genetics diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preimplantation genetics diagnosis companies profiled in this report include-

• Perkinelmer Agilent Technologies
• Cegat
• Laboratory Corporation Of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations (Rgi)

Preimplantation Genetics Diagnosis Market Insights

• Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.

• Hospitals will remain the largest segment due to increasing admissions of patients, improvement in healthcare infrastructure, and availability of public as well as private hospitals in the region.

• APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Features of the Global Preimplantation Genetics Diagnosis Market

• Market Size Estimates: Preimplantation genetics diagnosis market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Preimplantation genetics diagnosis market size by type, end use, and region. in terms of value ($B).

• Regional Analysis: Preimplantation genetics diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the preimplantation genetics diagnosis market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preimplantation genetics diagnosis market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the preimplantation genetics diagnosis market size?

Answer: The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030.

Q.2. What is the growth forecast for preimplantation genetics diagnosis market?

Answer: The global preimplantation genetics diagnosis market is expected to grow with a CAGR of 10.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the preimplantation genetics diagnosis market?

Answer: The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

Q.4. What are the major segments for preimplantation genetics diagnosis market?

Answer: The future of the preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets.

Q.5. Who are the key Preimplantation Genetics Diagnosis Market companies?

Answer: Some of the key preimplantation genetics diagnosis companies are as follows:

• PerkinElmer Agilent Technologies
• Cegat
• Laboratory Corporation of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations (RGI)

Q.6. Which preimplantation genetics diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.

Q.7. In preimplantation genetics diagnosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the preimplantation genetics diagnosis market by type (chromosomal abnormalities, aneuploidy, X-linked diseases,single gene disorders, HLA typing, gender selection, and others), end use (diagnostic laboratories, hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?